AeroLeads people directory · profile

Ganapathy Sarma Email & Phone Number

Director, Antibody Drug Conjugates at Exelixis
Location: San Francisco Bay Area, United States 8 work roles 3 schools
1 work email found @exelixis.com LinkedIn matched
✓ Verified Jul 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email g****@exelixis.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Director, Antibody Drug Conjugates
Location
San Francisco Bay Area, United States
Company size

Who is Ganapathy Sarma? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Ganapathy Sarma is listed as Director, Antibody Drug Conjugates at Exelixis, a with 51 employees, based in San Francisco Bay Area, United States. AeroLeads shows a work email signal at exelixis.com and a matched LinkedIn profile for Ganapathy Sarma.

Ganapathy Sarma previously worked as Director at Exelixis and Director, Bioconjugations at Bolt Biotherapeutics, Inc.. Ganapathy Sarma holds Doctor Of Philosophy (Ph.D.), Biochemistry And Biophysics from Oregon State University.

Company email context

Email format at Exelixis

This section adds company-level context without repeating Ganapathy Sarma's masked contact details.

{first_initial}{last}@exelixis.com
89% confidence

AeroLeads found 1 current-domain work email signal for Ganapathy Sarma. Compare company email patterns before reaching out.

Profile bio

About Ganapathy Sarma

• Conjugation chemist and antibody/protein design: Developed technologies for generating site-specific and random-conjugated ADCs through collaboration within and outside the company. Designed, generated and tested antibody and enzyme constructs using structure-based modeling for site-specific conjugation. • Antibody, protein and ADC purification: Over 10 years of experience in purifying proteins and antibodies (including ADCs) using affinity, charge-based, size-exclusion and hydrophobic-interaction chromatography techniques, normal flow filtration and tangential flow filtration. • Antibody and ADC purification downstream process development: Experienced in scaling up research-scale processes to development scale for transfer to manufacturing. Supported Manufacturing groups (internal and external) as subject matter expert for conjugation and purification. • Mentoring and leadership: Mentored and trained research associates and scientists in various techniques of conjugation, protein purification and biochemical analyses. Assisted the Protein Engineering Director in managing the research group and acted as a point person for scientists within the ADC (analytical and conjugation) group and other research groups. • Protein chemist with over 10 years of experience in characterizing protein function and protein-protein/protein-ligand interactions using structural, biophysical and biochemical and computational (homology modeling, structure-based design of payloads and enzymes) methods. • Collaborated closely with medicinal chemists to identify lead payloads, understand their mechanisms-of-action and optimizing them using structure-based and modeling techniques. • Excellent written and oral communication skills in the form of successful fellowship and grant applications, high-impact publications and invited talks.

Listed skills include Protein Purification, Protein Chemistry, Molecular Biology, Protein Expression, and 13 others.

Current workplace

Ganapathy Sarma's current company

Company context helps verify the profile and gives searchers a useful next step.

Exelixis
Exelixis
Director, Antibody Drug Conjugates
South San Francisco, CA
Website
Employees
51
AeroLeads page
8 roles

Ganapathy Sarma work experience

A career timeline built from the work history available for this profile.

Director

Current

Alameda, California, Us

Apr 2022 - Present

Senior Scientist

South San Francisco, California, Us

• Optimized conditions for site-specific, chemical conjugation of linker-payloads to monoclonal antibodies through collaborations within the company.• Initiated, optimized and developed methods for GLP- and GMP-scale conjugation and purification of different classes of linker-payloads to antibodies. • Developed, wrote and reviewed batch records, tech transfer documents, master procedures and development reports.• Worked closely with medicinal chemistry group on linker-payload design.• Closely involved in the transfer of optimized conjugation methods to manufacturing.• Successfully delivered high-quality results within time and budget for exploratory projects.• Mentored and trained research associates and scientists on conjugation and purification projects.

Sep 2016 - Nov 2017

Scientist

Lawrence Township, Nj, Us

• Initiated and developed methods for site-specific conjugation of drugs to monoclonal antibodies through collaborations within and outside the company.• Implemented structure-based modeling and docking methods for rational design of small molecules and novel sites for site-specific conjugation.• Designed mutant antibodies and enzymes for enzyme-based conjugation using homology modeling and protein-protein docking. • Successfully delivered high-quality results within time and budget for exploratory projects.• Recognized for outstanding performance in research and invited to present at BMS ADC meetings.

Oct 2011 - Aug 2016

American Heart Association Postdoctoral Associate

La Jolla, Ca, Us

Advisor: Dr. Susan S. Taylor• Initiated structural, biophysical and biochemical studies of D-AKAP2, an anchoring protein for cAMP-dependent protein kinase (PKA).• Determined the crystal structure of PKA regulatory subunit I in complex with D-AKAP2 using the weak anomalous signal from inherently present sulfur atoms by single wavelength anomalous diffraction (SAD).• Designed various D-AKAP2 constructs for structural and biophysical studies using bioinformatics, structure prediction programs, H/D exchange mass spectrometry and limited proteolysis.• Implemented biophysical and biochemical assays such as surface plasmon resonance, fluorescence polarization, and H/D exchange mass spectrometry to test and measure the interactions of shorter D-AKAP2 constructs with interacting proteins (Rab GTPases, PDZ proteins and PKA).• Discovered and defined the molecular code of AKAP specificity for the regulatory subunits of PKA, which is now the basis for designing peptide inhibitors in heart disease.• Discovered the mechanism of D-AKAP2 anchoring of PKA to the membrane by determining the ternary complex structure of D-AKAP2 with PKA and PDZ proteins. • Trained and mentored postdoctoral fellows, graduate and undergraduate students on research projects.

Nov 2005 - Sep 2011

Phd Student

Corvallis, Or, Us

Advisor: Dr. P. Andrew Karplus• Determined the structures of two antioxidant proteins – glutathione reductase (GR) and antioxidant protein (AOP) from the malarial parasite, Plasmodium falciparum.• Demonstrated that a cavity in PfGR could be a potential binding site for parasite-specific, non-competitive inhibitors and helped characterize the effect of various small molecules on its activity. This work provided the foundation for the development of a clinical, phase II trial anti-malarial drug.• Elucidated the mechanistic details of peroxide binding to PfAOP and its inactivation by over-oxidation.• Determined the crystal structure of fungal toxin, Pyrenophora tritici-repentis, Ptr ToxA using sulfur SAD phasing and its oligomerization state using dynamic light scattering, sedimentation equilibrium ultracentrifugation, analytical gel filtration (thesis research).• Proposed a mechanism for toxin recognition by an integrin-like membrane receptor, internalization and transport of the toxin to chlorophyll based on careful structural analyses. • Carried out detailed data analyses to study the effects of resolution, data redundancy and crystal decay on the ability to use sulfur atoms for SAD phasing.• Provided training to graduate and undergraduate students on various crystallography techniques.

Sep 2000 - Oct 2005
Team & coworkers

Colleagues at Exelixis

Other employees you can reach at exelixis.com. View company contacts for 51 employees →

3 education records

Ganapathy Sarma education

Doctor Of Philosophy (Ph.D.), Biochemistry And Biophysics

Oregon State University

Master’S Degree, Biochemistry

Tn Medical College, University Of Mumbai

Bsc, Biochemistry And Botany

University Of Mumbai
FAQ

Frequently asked questions about Ganapathy Sarma

Quick answers generated from the profile data available on this page.

What company does Ganapathy Sarma work for?

Ganapathy Sarma works for Exelixis.

What is Ganapathy Sarma's role at Exelixis?

Ganapathy Sarma is listed as Director, Antibody Drug Conjugates at Exelixis.

What is Ganapathy Sarma's email address?

AeroLeads has found 1 work email signal at @exelixis.com for Ganapathy Sarma at Exelixis.

Where is Ganapathy Sarma based?

Ganapathy Sarma is based in San Francisco Bay Area, United States while working with Exelixis.

What companies has Ganapathy Sarma worked for?

Ganapathy Sarma has worked for Exelixis, Bolt Biotherapeutics, Inc., Magenta Therapeutics, Sutro Biopharma, Inc., and Bristol-Myers Squibb.

Who are Ganapathy Sarma's colleagues at Exelixis?

Ganapathy Sarma's colleagues at Exelixis include Matthew Fong, Michael Shovlin, Zach Swinney, Ricky Wu, and Kathryn Maddocks.

How can I contact Ganapathy Sarma?

You can use AeroLeads to view verified contact signals for Ganapathy Sarma at Exelixis, including work email, phone, and LinkedIn data when available.

What schools did Ganapathy Sarma attend?

Ganapathy Sarma holds Doctor Of Philosophy (Ph.D.), Biochemistry And Biophysics from Oregon State University.

What skills is Ganapathy Sarma known for?

Ganapathy Sarma is listed with skills including Protein Purification, Protein Chemistry, Molecular Biology, Protein Expression, Biochemistry, Assay Development, Western Blotting, and Molecular Cloning.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.